New-look regional trains from 2013

Alstom has revealed the new look for its next-generation regional trains

Published Wednesday 30 November 2016 - 16:38 Modified Wednesday 30 November 2016 - 16:38

TRAIN manufacturer Alstom has revealed the new look for its next-generation regional trains.

The company has signed a deal to deliver 1,000 models between 2013 and 2025. The Régiolis models, above, which cost €9m per train, have been bought by 11 regional councils in France.

Other councils prefer to use the double-decker models built by France-based Alstom’s rival, Bombardier.

Councils are predicting the number of regional rail travellers will quadruple between now and 2030. A long-distance version that can travel at 200kmh is also being built.

travel and transport archive

IT issues and digitalisation of French residency cards ‘causing issues’

Foreigners face a ‘serious infringement of rights’ during application process

‘Check your rent is not too high’: Mixed reaction to new Paris poster

The campaign contributes to the ‘clichéd, outdated caricature of the chubby, arrogant landlord’, one property specialist says

See which offences can result in a car being impounded in France

There is also a time limit and set procedure to follow to recover a car

SNCF comes fifth in European ranking of best train companies

Eurostar did not fare quite so well

Letters: How are hybrid cars supposed to carry a spare tyre in France?

Connexion reader says electric vehicles simply do not have enough space

Ministers to debate emergency law so France can continue to collect tax and pay expenses

The text is used to guarantee that public services will continue to function while maintaining the same constraints as in last year’s budget

Legendary British cookery writer was inspired by Antibes - and its market

Sarah Hyde, who now lives in the town, explores Elizabeth David’s connection with its marché provençal. We also share one of her recipes

Eight common cold and cough medicines to be pulled from open sale in France

These drugs containing the vasoconstrictor pseudoephedrine are banned from over-the-counter sale from December 11 due to the increased risk of complications